Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Evogenom Oy
OY
Active
Y-tunnus 2786426-3
Elimäenkatu 17B-19, 00510
Helsinki
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
1 employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Evogenom Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JS
Johanna Sofia Lund
Chief Executive Officer
Chief Executive Officer
2024
Former (3)
HM
Hannu Matti Juhani Tolvanen
Chief Executive Officer
Chief Executive Officer
2016 – 2024
TT
Tanja Tuulikki Pajulampi
Audit
Audit
2019 – 2023
TK
Tapani Kristian Kärkkäinen
Audit
Audit
2019 – 2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
NF
Niko Frilander
Board of Directors
Board of Directors
2023
AS
Antti Samuli Seppä
Chairperson
Chairperson
2024
JO
Joni Olli Antero Kettunen
Board of Directors
Board of Directors
2021
SA
Simo Antero Huvila
Board of Directors
Board of Directors
2024
Former (11)
HK
Harri Kristian Sillgren
Board of Directors
Board of Directors
2017 – 2025
TS
Tiia-Tyttö Suutari
Board of Directors
Board of Directors
2017 – 2023
ES
Esa Sakari Vilmusenaho
Board of Directors
Board of Directors
2017 – 2019
MI
Merja Inkeri Auvinen
Board of Directors
Board of Directors
2021 – 2024
SA
Seppo Ari Sneck
Board of Directors
Board of Directors
2019 – 2021
MJ
Mika Johannes Nurmikolu
Board of Directors
Board of Directors
2017 – 2019
IK
Ilkka Kalervo Uusi-Maahi
Board of Directors
Board of Directors
2023 – 2025
RI
Riku Ilmari Kokkonen
Board of Directors
Board of Directors
2017 – 2021
SA
Sami Anssi Kähärä
Board of Directors
Board of Directors
2019 – 2020
SM
Sami Markus Kortelahti
Board of Directors
Board of Directors
2021 – 2026
OE
Olli Eljas Porkholm
Chairperson
Chairperson
2021 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Evogenom Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network